CUROSURF 120 mg/1.5 ml, suspension for endotracheobronchial instillation bottle, 1.5 ml
Active ingredients: Poractant alfa
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Suspension for instillationbottle, 1.5 mlendotrachéobronchique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CUROSURF 120 mg/1,5 ml, suspension pour instillation endotrachéobronchique
- Pharmaceutical form
- suspension pour instillation
- Route of administration
- endotrachéobronchique
- Presentation description
- 1 flacon(s) en verre de 1,5 ml
- Marketing authorisation holder
- CHIESI
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Jan 1993
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60301200CIP75577520CIP133400955775201Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PORACTANT ALFAsuspension | 120 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.